Possible fatal interaction between protease inhibitors and methamphetamine.
Hales
G
G
Roth
N
N
Smith
D
D
D019380:Anti-HIV Agents / Q000627:therapeutic use; D000697:Central Nervous System Stimulants / Q000097:blood / Q000506:poisoning*; D004347:Drug Interactions; D004359:Drug Therapy, Combination; D017809:Fatal Outcome; D015658:HIV Infections / Q000188:drug therapy*; D017320:HIV Protease Inhibitors / Q000009:adverse effects*; D006801:Humans; D008297:Male; D008694:Methamphetamine / Q000097:blood / Q000506:poisoning*; D008875:Middle Aged; D018894:Reverse Transcriptase Inhibitors / Q000627:therapeutic use; D019438:Ritonavir / Q000009:adverse effects*; D019258:Saquinavir / Q000009:adverse effects*; D018119:Stavudine / Q000627:therapeutic use
D019380:Anti-HIV Agents; D000697:Central Nervous System Stimulants; D017320:HIV Protease Inhibitors; D018894:Reverse Transcriptase Inhibitors; D008694:Methamphetamine; D018119:Stavudine; D019258:Saquinavir; D019438:Ritonavir